Yin, Honglei <br/><br/>
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways.  [electronic resource] 

 -  Molecular medicine reports  May 2014 
 - 1834-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Retracted Publication 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2014.2051  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Disease Models, Animal<br/>Echocardiography<br/>Inflammation--metabolism<br/>Interleukin-33<br/>Interleukins--pharmacology<br/>Mice<br/>Myocardial Infarction--metabolism<br/>Myocardium--metabolism<br/>NF-kappa B--metabolism<br/>Phosphorylation--drug effects<br/>Signal Transduction--drug effects<br/>Ventricular Function, Left<br/>Ventricular Remodeling--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism